Canada Greenlights ALS Drug As US Regulators Face Pressure During Review
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
Amyotrophic lateral sclerosis (ALS) is one of the most difficult diseases in the world to treat. Its cause is still a mystery to doctors. And the disease's unforgiving progression -- which sees a breakdown of nerve cells in the brain and spinal cord -- leads to severe disability and death.
On Monday, there was a glimmer of hope for some, as Canadian health regulators approved a new treatment for ALS for the first time since 2018. But the drug faces an uncertain path down south.
Source Fool.com
